Altering the Biology of Myelodysplastic Syndromes With Luspatercept
In an interview with Targeted Oncology, Guillermo Garcia-Manero, MD, discusses the COMMANDS trial, a section 3 examine evaluating luspatercept (Reblozy)…
Altering the Biology of Myelodysplastic Syndromes With Luspatercept Read More